BTL Industries, founded in 1993, stands as a key player in the Industrial, Manufacturing, and Medical Devices sectors. Renowned for being a global innovator of medical and aesthetic solutions, the company operates from its headquarters in the United Kingdom. With over 4500 employees and a robust team of 600 R&D engineers, BTL has established a formidable presence across 90 countries on five continents.
The company's product offerings are diverse, catering primarily to cardiology, pneumology, physical therapy, and medical aesthetics. Notably, their medical aesthetic line includes cutting-edge, non-invasive technologies aimed at body shaping, skin tightening, and more.
BTL integrates direct sales subsidiaries with a strong network of independent distributors. The company's US operations are based in Boston, Massachusetts. Adhering to rigorous quality standards, BTL maintains an ISO 13485 certified system, ensuring GMP compliance. Its products feature recognized certifications like CE mark, US FDA clearance, and Health Canada licensing. Currently, there is no record of recent investments.